Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Faron Pharmaceuticals Share News (FARN)
FARN Share
Price
FARN Share
News
FARN Share
Chat
FARN Share
Trades1
FARN
Live RNS
FARN Share
Charts
FARN Level 2
Console
FARN Live
Share Price
FARN Broker
Ratings
FARN Directors
Deals
FARN Financial
Diary
FARN
Fundamentals
FARN Short
Positions
FARN
Media
FARN Company
Research
FARN Company
Timeline
Faron Pharmaceuticals Information
Share Price Information for Faron Pharmaceuticals (FARN)
Share Price is delayed by 15 minutes
Get Live Data
46.00
0.00 (0.00%)
Bid:
45.00
Ask:
47.00
Spread:
2.00 (4.444%)
Market Cap:
£91.78m
Last checked at -
Last checked at 
Intraday Faron Pharmaceuticals Share Chart
Faron Pharmaceuticals News
21 Apr 2020
Faron Pharmaceuticals Plans Private Placing To Raise EUR10 Million
Faron Pharmaceuticals Plans Private Placing To Raise EUR10 Million
1 Apr 2020
UK TRADING UPDATE SUMMARY: Watkin Jones Cancels Payout, Halts Work
UK TRADING UPDATE SUMMARY: Watkin Jones Cancels Payout, Halts Work
20 Mar 2020
Research And Development Expense Drop Cuts Faron Pharmaceuticals Loss
Research And Development Expense Drop Cuts Faron Pharmaceuticals Loss
20 Mar 2020
UK WINNERS & LOSERS SUMMARY: Future Surges As It Sees Results In Line
UK WINNERS & LOSERS SUMMARY: Future Surges As It Sees Results In Line
13 Mar 2020
UK Earnings, Trading Statements Calendar - Next 7 Days
UK Earnings, Trading Statements Calendar - Next 7 Days
9 Mar 2020
Faron Pharmaceuticals Gets Green Light For New Traumakine Trial
Faron Pharmaceuticals Gets Green Light For New Traumakine Trial
9 Mar 2020
Faron gets FDA tick from proposed design of next 'Traumakine' study
(Sharecast News) - Faron Pharmaceuticals announced on Monday that the US Food and Drug Administration (FDA) has accepted its proposed protocol design ...
5 Mar 2020
Faron Pharmaceuticals "Encouraged" After Latest Matins Trial Findings
Faron Pharmaceuticals "Encouraged" After Latest Matins Trial Findings
Follow the stocks
